JP2023527200A5 - - Google Patents

Info

Publication number
JP2023527200A5
JP2023527200A5 JP2022573173A JP2022573173A JP2023527200A5 JP 2023527200 A5 JP2023527200 A5 JP 2023527200A5 JP 2022573173 A JP2022573173 A JP 2022573173A JP 2022573173 A JP2022573173 A JP 2022573173A JP 2023527200 A5 JP2023527200 A5 JP 2023527200A5
Authority
JP
Japan
Prior art keywords
antibody
use according
seq
subject
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022573173A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023527200A (ja
JP7841752B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/054652 external-priority patent/WO2021240436A1/en
Publication of JP2023527200A publication Critical patent/JP2023527200A/ja
Publication of JP2023527200A5 publication Critical patent/JP2023527200A5/ja
Application granted granted Critical
Publication of JP7841752B2 publication Critical patent/JP7841752B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022573173A 2020-05-29 2021-05-27 関節リウマチを有する対象における非炎症性疼痛を治療するための組成物および方法 Active JP7841752B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202063032035P 2020-05-29 2020-05-29
US63/032,035 2020-05-29
US202063077378P 2020-09-11 2020-09-11
US63/077,378 2020-09-11
EP21315081.6 2021-05-11
EP21315081 2021-05-11
PCT/IB2021/054652 WO2021240436A1 (en) 2020-05-29 2021-05-27 Compositions and methods for treating noninflammatory pain in subjects with rheumatoid arthritis

Publications (3)

Publication Number Publication Date
JP2023527200A JP2023527200A (ja) 2023-06-27
JP2023527200A5 true JP2023527200A5 (cg-RX-API-DMAC7.html) 2024-06-03
JP7841752B2 JP7841752B2 (ja) 2026-04-07

Family

ID=76269781

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022573173A Active JP7841752B2 (ja) 2020-05-29 2021-05-27 関節リウマチを有する対象における非炎症性疼痛を治療するための組成物および方法

Country Status (12)

Country Link
US (1) US20230192871A1 (cg-RX-API-DMAC7.html)
EP (1) EP4157450A1 (cg-RX-API-DMAC7.html)
JP (1) JP7841752B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230018443A (cg-RX-API-DMAC7.html)
CN (1) CN115697486A (cg-RX-API-DMAC7.html)
AU (1) AU2021279412A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022023949A2 (cg-RX-API-DMAC7.html)
CA (1) CA3180041A1 (cg-RX-API-DMAC7.html)
CO (1) CO2022017828A2 (cg-RX-API-DMAC7.html)
IL (1) IL298087A (cg-RX-API-DMAC7.html)
MX (1) MX2022015030A (cg-RX-API-DMAC7.html)
WO (1) WO2021240436A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022545312A (ja) 2019-04-24 2022-10-27 サノフィ・バイオテクノロジー 関節リウマチの診断及び処置の方法
CA3142710A1 (en) 2019-06-04 2020-12-10 Sanofi Biotechnology Compositions and methods for treating pain in subjects with rheumatoid arthritis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215534A (en) 1991-12-02 1993-06-01 Lawrence De Harde Safety syringe system
US6659982B2 (en) 2000-05-08 2003-12-09 Sterling Medivations, Inc. Micro infusion drug delivery device
US6629949B1 (en) 2000-05-08 2003-10-07 Sterling Medivations, Inc. Micro infusion drug delivery device
ATE537190T1 (de) 2006-06-02 2011-12-15 Regeneron Pharma Hochaffine antikörper gegen den humanen il-6- rezeptor
JO3417B1 (ar) 2010-01-08 2019-10-20 Regeneron Pharma الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r
US9427531B2 (en) 2010-06-28 2016-08-30 Sanofi-Aventis Deutschland Gmbh Auto-injector
US9248242B2 (en) 2012-04-20 2016-02-02 Safety Syringes, Inc. Anti-needle stick safety device for injection device
US20140155827A1 (en) 2012-12-03 2014-06-05 Mylan, Inc. Medicament information system and method
JP7101479B2 (ja) * 2014-09-16 2022-07-15 サノフィ・バイオテクノロジー 関節リウマチ患者の健康に関連した生活の質を改善するための組成物

Similar Documents

Publication Publication Date Title
JP2024069453A5 (cg-RX-API-DMAC7.html)
US20220002402A1 (en) Methods of treating graves' ophthalmopathy using anti-fcrn antibodies
US20220073596A1 (en) Method for the treatment of idiopathic pulmonary fibrosis
JP2015514110A5 (cg-RX-API-DMAC7.html)
JP2020505386A5 (cg-RX-API-DMAC7.html)
JP2019521647A5 (cg-RX-API-DMAC7.html)
JP2018537418A5 (cg-RX-API-DMAC7.html)
WO2017059813A1 (zh) 抗乙肝表面抗原的抗体及其用途
JP2021511024A5 (cg-RX-API-DMAC7.html)
JP2022534794A5 (cg-RX-API-DMAC7.html)
JP2018529661A5 (cg-RX-API-DMAC7.html)
JP2022522815A5 (cg-RX-API-DMAC7.html)
SG194362A1 (en) Composition for treating disease
CN106573059A (zh) 接受过抗TNF‑α抗体疗法的银屑病患者的治疗方法
JP2025515337A5 (cg-RX-API-DMAC7.html)
JP2022514561A5 (cg-RX-API-DMAC7.html)
EP2663329A2 (en) Tlr3 binding agents
JP2024528877A5 (cg-RX-API-DMAC7.html)
JP2023527059A5 (cg-RX-API-DMAC7.html)
JP2023506779A5 (cg-RX-API-DMAC7.html)
CN113316587A (zh) 一种双特异性分子及其制备与用途
JP2025510815A5 (cg-RX-API-DMAC7.html)
JP2024522620A5 (cg-RX-API-DMAC7.html)
TW202114734A (zh) Il-17拮抗劑治療自身免疫疾病的方法
RU2021138376A (ru) Композиции и способы лечения боли у субъектов с ревматоидным артритом